Loading clinical trials...
Loading clinical trials...
Effects of Remimazolam on the Intraoperative Hemodynamic Parameters in Patients Undergoing Extracranial-intracranial Bypass Surgery: a Prospective Randomized Controlled Trial
This study is a randomized, controlled trial. A total of 72 patients will be randomized to receive remimazolam anesthesia or balanced anesthesia (propofol + desflurane) during extracranial-intracranial bypass surgery.
Age
19 - No limit years
Sex
ALL
Healthy Volunteers
No
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Start Date
October 20, 2022
Primary Completion Date
October 30, 2023
Completion Date
December 30, 2023
Last Updated
October 27, 2022
72
ESTIMATED participants
Remimazolam
DRUG
Balanced Anesthesia
DRUG
Lead Sponsor
Seoul National University Hospital
NCT07134530
NCT06753097
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06707428